Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesPolymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects
International Journal of Cancer, 06/11/09
McColgan P et al. - In a study to examine polymorphisms of matrix metalloproteinases (MMP) 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer (CRC) in over 30,000 subjects, it appears that there may be a genetic influence in development of CRC and lung cancer. Subjects with the MMP-1 nt-1607 polymorphism have an increased association with CRC. Those homozygous for either the MMP-2/1306T or 735T allele may be at reduced risk of lung cancer, although the evidence base is small.
Methods- A comprehensive genetic meta-analysis was done of all MMP genes investigated using an allelic-association case-control model in the 3 major cancers of lung, breast and CRC.
- Electronic databases were searched until and including July 2008 for any MMP genetic association study in lung, breast, and CRC.
- Odds ratio (OR) and 95% confidence intervals (CI) were determined for each gene disease association using fixed and random effect models.
- 25 studies addressing 5 polymorphisms in 4 genes were analyzed among 30,651 individuals (15,328 cases and 15,253 controls).
- The MMP-1 nt-1607 polymorphism was significantly associated with CRC in both the dominant and recessive models.
- MMP-21306CT and 735CT were significantly associated with protection against lung cancer.
- No association was found with the MMP 1, 2, 3 or 9 polymorphisms with breast cancer, MMP-1, 3, or 9 with lung cancer or MMP-2, 3 or 9 with CRC.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Polymorphisms in the CASPASE Genes and Survival in Patients With Early-Stage Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 10/16/09
Absence of inflammation and pneumonia during infection with non-pigmented Yersinia pestis reveals new role for the pgm locus in pathogenesis
Infection and Immunity, 10/30/09
Association and interaction analyses of eight genes under asthma linkage peaks
Allergy, 10/15/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer
Annals of Oncology, 10/19/09
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase III study
The Lancet, 10/26/09
Sponsor
Article Search
Sponsor